The introduction of dengue vaccine may temporarily cause large spikes in prevalence

Epidemiology and Infection

Volumn 143, Issue 6, 2015, Pages 1276-1286

  Pandey, A ^a   Medlock, J ^b  

^a CLEMSON UNIVERSITY   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

Dengue; Vaccination; Vaccination effectiveness

Indexed keywords

DENGUE VACCINE;

ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE TRANSMISSION; DRUG EFFICACY; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; MATHEMATICAL MODEL; MEDICAL DECISION MAKING; MEDICAL SERVICE; NONHUMAN; OUTCOME ASSESSMENT; PREDICTION; PREVALENCE; SENSITIVITY ANALYSIS; VACCINATION; VACCINE PRODUCTION; DENGUE; DENGUE VIRUS; PREVENTIVE HEALTH SERVICE; PROCEDURES; STATISTICAL MODEL; TRANSMISSION;

DENGUE; DENGUE VACCINES; DENGUE VIRUS; HUMANS; IMMUNIZATION PROGRAMS; MODELS, STATISTICAL; PREVALENCE;

EID: 84925044890     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268814001939     Document Type: Article

References (21)

1. Guzmán MG, Kouri G. Dengue: an update. Lancet Infectious Diseases 2002; 2: 33-42.
2. Nagao Y, Koelle K. Decreases in dengue transmission may act to increase the incidence of dengue hemorrhagic fever. Proceedings of the National Academy of Sciences USA 2008; 105: 2238-2243.
3. Guzmán MG, et al. Dengue: a continuing global threat. Nature Reviews Microbiology 2010; 8: S7-S16.
4. Beatty M, et al. Assessing the potential of a candidate dengue vaccine with mathematical modeling. PLoS Neglected Tropical Diseases 2012; 6: e1450.
5. Coller BAG, Clements DE. Dengue vaccines: progress and challenges. Current Opinion in Immunology 2011; 23: 391-398.
6. Halstead SB. Dengue vaccine development: a 75% solution? Lancet 2012; 380: 1535-1536.
7. Reich NG, et al. Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity. Journal of the Royal Society Interface 2013; 10: 20130414.
8. Halstead SB. Neutralization and antibody-dependent enhancement of dengue viruses. Advances in Virus Research 2003; 60: 421-467.
9. Rajapakse S. Dengue shock. Journal of Emergencies, Trauma and Shock 2011; 4: 120.
10. Pandey A, Mubayi A, Medlock J. Comparing vector-host and SIR models for dengue transmission. Mathematical Biosciences 2013; 246: 252-259.
11. Nisalak A, et al. Serotype-specific dengue virus circulation and dengue disease in bangkok, thailand from 1973 to 1999. American Journal of Tropical Medicine and Hygiene 2003; 68: 191-202.
12. Strogatz SH. Nonlinear Dynamics and Chaos: with Applications to Physics, Biology, Chemistry, and Engineering. Boulder, CO: Westview Press, 1994.
13. Wearing HJ, Rohani P. Ecological and immunological determinants of dengue epidemics. Proceedings of the National Academy of Sciences USA 2006; 103: 11802-11807.
14. King AA, et al. Weakly dissipative predator-prey systems. Bulletin of Mathematical Biology 1996; 58: 835-859.
15. Keeling M, Grenfell B. Disease extinction and community size: modeling the persistence of measles. Science 1997; 275: 65-67.
16. King AA, Schaffer WM. The rainbowbridge:Hamiltonian limits and resonance in predator-prey dynamics. Journal of Mathematical Biology 1999; 39: 439-469.
17. Grenfell B, Bjørnstad O, Kappey J. Travelling waves and spatial hierarchies in measles epidemics. Nature 2001; 414: 716-723.
18. Cummings DAT, et al. Dynamic effects of antibody-dependent enhancement on the fitness of viruses. Proceedings of the National Academy of Sciences USA 2005; 102: 15259-15264.
19. Billings L, Fiorillo A, Schwartz IB. Vaccinations in disease models with antibody-dependent enhancement. Mathematical Biosciences 2008; 211: 265-281.
20. Gubler DJ. Dengue and dengue hemorrhagic fever. Clinical Microbiology Reviews 1998; 11: 480-496.
21. Keeling M, Rohani P. Modeling Infectious Diseases in Humans and Animals. Princeton: Princeton University Press, 2011.